-
After promising radiopharmaceuticals in the research phase, MU pioneers a cancer-killing isotope.
-
No-carrier added Lutetium-177 is a highly pure radioisotope that could be used to develop cancer treatments.
-
With a $3.7 million federal grant, MU is taking the first step in an effort to produce a more effective immunotherapy treatment for cancer patients.This…